- Home
- ABEO vs RZLT Comparison
ABEO vs RZLT Comparison
Compare ABEO & RZLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABEO
- RZLT
- Stock Information
- Founded
- ABEO N/A
- RZLT 2010
- Country
- ABEO United States
- RZLT United States
- Employees
- ABEO N/A
- RZLT N/A
- Industry
- ABEO Biotechnology: Pharmaceutical Preparations
- RZLT Biotechnology: Pharmaceutical Preparations
- Sector
- ABEO Health Care
- RZLT Health Care
- Exchange
- ABEO Nasdaq
- RZLT Nasdaq
- Market Cap
- ABEO 247.8M
- RZLT 292.0M
- IPO Year
- ABEO 1980
- RZLT N/A
- Fundamental
- Price
- ABEO $5.70
- RZLT $4.39
- Analyst Decision
- ABEO Strong Buy
- RZLT Strong Buy
- Analyst Count
- ABEO 3
- RZLT 8
- Target Price
- ABEO $18.00
- RZLT $11.63
- AVG Volume (30 Days)
- ABEO 229.2K
- RZLT 388.5K
- Earning Date
- ABEO 11-14-2024
- RZLT 02-11-2025
- Dividend Yield
- ABEO N/A
- RZLT N/A
- EPS Growth
- ABEO N/A
- RZLT N/A
- EPS
- ABEO N/A
- RZLT N/A
- Revenue
- ABEO N/A
- RZLT N/A
- Revenue This Year
- ABEO N/A
- RZLT N/A
- Revenue Next Year
- ABEO $18,714.71
- RZLT N/A
- P/E Ratio
- ABEO N/A
- RZLT N/A
- Revenue Growth
- ABEO 147.52
- RZLT N/A
- 52 Week Low
- ABEO $3.05
- RZLT $0.88
- 52 Week High
- ABEO $9.01
- RZLT $6.19
- Technical
- Relative Strength Index (RSI)
- ABEO 34.30
- RZLT 37.77
- Support Level
- ABEO $5.45
- RZLT $4.07
- Resistance Level
- ABEO $6.04
- RZLT $4.64
- Average True Range (ATR)
- ABEO 0.19
- RZLT 0.36
- MACD
- ABEO -0.04
- RZLT -0.07
- Stochastic Oscillator
- ABEO 19.47
- RZLT 21.92
About ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel AIM.
About RZLT Rezolute Inc. (NV)
Rezolute Inc is a biopharmaceutical company. The company develops novel, sustained-release injectable therapies. It applies proprietary formulation and manufacturing capabilities to known, well-characterized molecules to create differentiated, patent-protected therapies that have the potential to significantly improve existing standards of care. Its pipeline products include RZ358 and RZ402.